Jasper Therapeutics Capital Expenditures (CapEx) Growth & History (JSPR)

Jasper Therapeutics's capital expenditures (capex) was $7,000 for fiscal 2025.

View full Jasper Therapeutics company overview

Jasper Therapeutics annual capital expenditures (capex) history

Jasper Therapeutics annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$7,000−$545,000−98.73%
20242024-12-31$552,000$285,000+106.74%
20232023-12-31$267,000−$309,000−53.65%
20222022-12-31$576,000−$1.9M−76.28%
20212021-12-31$2.4M

Jasper Therapeutics capital expenditures (capex) trends

Between the periods ended 2021-12-31 and 2025-12-31, Jasper Therapeutics's capital expenditures (capex) decreased from $2.4M to $7,000, a change of −$2.4M. The latest reported quarter, Q3 2025, shows $0.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Jasper Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about JSPR yet. Start the conversation.

Write the first post